chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX (Merck) which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the VARIVAX (Merck) information (patient identifiers, lot numbers and expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 13-18, units not reported) of unknown gender. On 15-SEP-201, the patient was vaccinated with a dose of VARIVAX (Merck) which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Case number PHEH2014US0255051 is an initial spontaneous report received from a pharmacist on 11 Dec 2014. This report refers to a patient of unknown age and gender. Past medical history and concomitant medications were not reported. On 10 Dec 2014, the patient was vaccinated with FLUVIRIN (batch number: 1414101) intramuscularly, that had been at 32 F for up to 3 days and vaccine did not appear frozen. No adverse event was reported following this administration error.
The patient experienced an injection site reaction to a ZOSTAVAX vaccination shortly after receiving the injection. The symptoms included pain, swelling, redness, and warmth at the site of injection which lasted for approximately four days. The patient also had a headache that lasted for four days after the injection. The patient took Ibuprofen intermittently to relieve pain. The symptoms resolved after approximately four days.
The patient is 66-year-old male with history of lymphoma, previous history of Covid pneumonia 9 months ago, fully vaccinated for COVID-19 was admitted with shortness of breath.  He was diagnosed with COVID-19 pneumonia.  At some point was started on heated flow due to significant hypoxia.  Patient was treated with with steroids, antibiotics, he was not given remdesivir due to the late presentation. Baricitinib given for few days, later on discontinued due to further elevation of his white count.  Had a CT of the chest that did not show any pulmonary embolus but multifocal pneumonia.  All respiratory measures have been tried and they have been not successful. Patient requires oxygen via nasal cannula due to prolonged hypoxia.  Of note antibody were checked and they have been negative for Covid.  The provider had discussion with patient about his immune system being very weak and unable to make antibodies.  He is at high risk for repeating COVID-19 infections and other viral infections.
Hives and rash with pruritus. Went to ED x2 on 9/14 and 9/15 reportedly received steroid injection and prescribed prednisone, famotidine, and diphenhydramine. Came to office on 9/17/19 for f/u with ongoing sx. Steroid course extended, added cetirizine. No sx of anaphylaxis.
Pt began crying @ 1130am & stopped about 3 pm when she fell asleep. She was unconsolable & the cry was high pitched. Could be heard in the background while we talked w/ mom.
chills, shaking, vomiting many times (over the course of several hours), headache
Extreme pain approximately  4 hrs after injection. Took 2 tylenol. Pain slightly  subsided. Next morning soreness
At approx. 8:30pm arm felt sore; headache; chills; went to bed; slept;11/18 - had fever 99.6-100.0F.; fatigue; arm swollen, hot and very sore; 11/19 - no fever, generally felt better, but arm still sore
Moderna COVID 19 Vaccine EUA patient complains of shoulder pain at injection site, body aches and sweating throughout the night. Body aches the next morning in to the evening , cold in the Am, Hot in the afternoon. No site reactions. Fever with no documented temp. Took Tylenol 1000mg for the symptoms.
Pfizer-BioNTech COVID 19 vaccine EUA  - 1/27/21 received vaccine took 2 extra strength Tylenol 1 hour prior @ 6PM sore arm, took 2 more extra strength Tylenol before bed. 1/28/21 sore arm, chills, aches & mild nausea- took 2 Tylenol
2 days after immunization localized whelping to cellulitis 12cm x 6cm over injection site.
1/18/22 pt had a positive COVID test at Hospital; was brought from Nursing and Rehab; admitted with AMS; full code status; required intubation; hypotensive; started on sepsis bundle IVFs and empiric ABX; required ICU with AHRF; metabolic encephalopathy; 2/8/22 was dc'd back to facility from hospital; 3/1/22 pt found unresponsive; CPR started; EMS called and took over CPR once they got there without success; pt expired in the facility.
within 24 hours. withdrawn, loss of speech, repetitive behaviors, loss of eye contact, loss of interest in other children and most people in general. He became Autistic within 24 hours. 1/26/2010 Follow-up: He became autistic withine 24 hours after receiving those shots.
extreem fatigue for several days, missed work. Then on October 20th, started getting chest pains. They continued getting worse despite visiting my doctor. Went to the local County Hospital Emergency Room on November 2, 2021 because it felt like I was having a heart attack. This was a vaccine I did NOT want and was done under coercion. I have also experienced significant weight gain despite diet and exercise, lifestyle change and energy has decreased. I also have trouble breathing going up stairs which I have never experienced before in my life. This vaccine has been extremely damaging.
Approximately one hour after receiving vaccine throat became sore, chest filled up - congestion and cough, SOB. No fever. H/o asthma. Took prescribed asthma medications. Stayed like this no improvement. Did not see physician. Advise to see own physician at this time as symptoms have improved only slightly.
(R) arm immediate pain, nausea-fever during night to 101 degrees. Redness soreness, vomiting, 4"x4" area. Had 2 bad days ill. Rx KEFLEX.
tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported that a male patient (husband) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient have their second dose appointment scheduled for 21Apr2021, and would like to cancel appointments as both tested positive for COVID. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
No adverse effects at the time of injection.  But patient died of Sudden infant death syndrome at a later date 07/29/2008 9/22/08-autopsy report received;COD-Asphyxia due to overlay due to co-sleeping with older sibling and parents in same bed. Petechiae of eyes.
2 months ago he started to feel his arm tingling; Had cramps in this arm; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (2 months ago he started to feel his arm tingling) and MUSCLE SPASMS (Had cramps in this arm) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025LC20A, 032L20A and 033421A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2022, the patient experienced PARAESTHESIA (2 months ago he started to feel his arm tingling) and MUSCLE SPASMS (Had cramps in this arm). At the time of the report, PARAESTHESIA (2 months ago he started to feel his arm tingling) and MUSCLE SPASMS (Had cramps in this arm) outcome was unknown.      No concomitant medication was provided by reporter.  Patient had no allergies. The patient never tested positive for Covid19. The patient visited the neurologist, but they just had done an MRI and no treatment. Doctor thought the nerve might be pinched. Patient received concomitant medication but had not specified.  No treatment medication was provided by reporter.
Chills; seems to have some kind of hypothermia/kept reading 94.7; hemorrhoids; pulmonary embolism in his right lower lobe; This is a spontaneous report from a contactable pharmacist (patient).  A 68-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 03Mar2021 (Batch/Lot Number: EN6198; Expiration Date: 30Jun2021), at the age of 68-years at vaccination, as SINGLE DOSE for COVID-19 immunisation. Medical history included paraplegic, he has been paralyzed for 45 years. The patient received first dose of the vaccine on 10Feb2021 with lot number: EN5318, expiration 31May2021. There were no concomitant medications.  The patient went on Monday to the ER for an unrelated condition and they did a CT scan and found a blood clot, a pulmonary embolism in his right lower lobe. He confirms the pulmonary embolism was diagnosed on Monday, 15Mar2021.  He got home that night and read the headline in the (Withheld) times that said several European countries are pulling the Astra Zeneca vaccine over concerns about blood clots even though there has not been any causal relationship found. He thought that with the drug companies, they should be able to have data regarding potential adverse effects for Pfizer so he was calling report that. He discusses it with the ER doctor and he couldn't really figure out why he had a blood clot, it was incidental to what he was being scanned for, it surprised him. They put him on Eliquis so he is on an anticoagulant, which will cost him a fortune. Today will be the third day he has been on the Eliquis. He is at home and he would say his only concern is that he does have hemorrhoids so when he has bowel movement tomorrow, because he doesn't go every day, but when he goes he is concerned if he starts to bleed that the anti-coagulant might cause the bleeding to be more significant than it usually is. No further information provided. His only other concern is he seems to have some kind of hypothermia, he is not entirely sure because of his thermometer is not very good. That is the reason he went into the Emergency Department because it kept reading 94.7 and he googled it and it said if it is below 95 it is a medical emergency and go to the ER so he got to the Emergency Department and it was 97.6 and now he checked his temperature again with the thermometer and it was 96.8 so either he has a faulty thermometer or something but he is experiencing some kind of chills.  The outcome of the events was unknown.
1st dose on 2013, 2nd never; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old male patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (first dose of Twinrix back in 2013).   On an unknown date, the patient received the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose on 2013, 2nd never). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-MAY-2023 The doctor of medicine reported that the patient never completed the scheme up to the reporting date. The health care professional reported that the serological test was performed which showed that the patient was reactive to hepatitis A but not to Hepatitis B. Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination. The reporter consented to follow up.
arm was really red, painful, swollen and on fire; nauseated; sleepy;Initial information regarding an unsolicited valid non-serious case was received from a consumer/non-health care professional via Medical Information (Reference number- 00585546) and transmitted to Sanofi on 03-May-2021.   This case involves a 64 years old female patient whose arm was really red, painful, swollen and on fire (inflammation), was nauseated (nausea) and sleepy (somnolence) after receiving INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE [FLUZONE] and while being treated with DIPHENHYDRAMINE HYDROCHLORIDE [BENADRYL].  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On 19-Oct-2010, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE (lot U3734AA, Suspension for injection) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patients arm was really red, painful, swollen and on fire (inflammation) (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE.   The patient took 2 (ADVIL [IBUPROFEN]), however the swelling increased for 2 hours, until it was so bad that she was scared, and had to go to the emergency room (ER). In the ER, her arm was really swollen, red, and on fire.   The patient thought she received Benadryl (date unspecified) and then she was nauseated (nausea), she thought that they inserted an intravenous (IV) but she was not sure because she was so sleepy (somnolence) (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE and being treated with DIPHENHYDRAMINE HYDROCHLORIDE.  She was then discharged (date unspecified). The health care professional (HCP) that discharged her stated that she should not receive any more flu shots because they now contain the avian bird flu H1N1 and she had a reaction and her next reaction could be much worse. She asked if it was a specific batch that landed her in the ER after her Fluzone injection on 19-Oct-2010. There was difficulty reading the Lot and what was on the vial, due to the writing being small.  The events were non-serious  The reporter stated that she wanted to visit her mother in the nursing home but the management was insisting that she receive the coronavirus (COVID) vaccine in order to see her mother. The patient stated that she had a reaction to the H1N1 portion of the 2010 Fluzone vaccine and she believed that the COVID vaccines have the H1N1 in them and will make her sick  One of the HCP's in a white lab coat stated to the patient that it must be why so many people are having reactions to the COVID vaccines because so many people got sick after getting the Flu vaccines with the added H1N1.   It is unknown if the patient experienced any additional symptoms/events  It is unknown if there were lab data/results available  At time of reporting, the outcome of events was unknown.
Sore throat; ear pain; fever; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm  on 31Mar2021 at 09:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and high blood pressure. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 20:00,  the patient experienced sore throat, fever and ear pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of sore throat, fever and  ear pain were unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Chest pain; numb hands; This is a spontaneous report from a contactable consumer, reporting for herself.  A 38-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 19Jan2021 at 10:30 (at the age of 38 years old) as a single dose in the right arm for COVID-19 vaccination. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Jan2021, the patient experienced chest pain and numb hands. The patient did not receive treatment for the events. The clinical outcome of chest pain and numb hands was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
patient was given Shingrix vaccine was not mixed correctly. it was mixed with sterile diluent instead of Adjuvant suspension Component. Vaccineinfo @kingcounty was notified. was informed Shingrix given is invalied and to repeat in 4 weeks. informed patient. patient has no symptoms. .
Vomiting; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) and HEADACHE (Headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VOMITING (Vomiting) and HEADACHE (Headaches). At the time of the report, VOMITING (Vomiting) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment medications were not provided by reporter.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Rash developed and three weeks later there is still a mark. The rash is not itchy or sore.
This spontaneous report was received from a back office lead and refers to a 69 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 05-APR-2106, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (lot # L042846 and expiration date: 15-SEP-2017) 1 ml, intramuscularly, into deltoid (dose number was not provided). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2 (BNT162B2), on 22Oct2021 as dose 3 (booster), single (Lot number: FC3183) at the age of 34 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Other medication in 2 weeks reporter as No. Paxlovid used as COVID 19 Treatment started on 11Jun2022 and stopped on 15Jun2022. Tested negative for 3 straight days after Paxlovid and on day 4 I developed a strong cough. Retested and the result was strong positive and immediate on a PCR.
large red rash, swelling of arm at injection site, vomiting x 1 day post vaccination. pt also reported hives, itching and peeling of skin at injection site
Developed sore throat 30 hours after injection. Sore throat worsened and persists now - currently 72 hours into codition.
Systemic: Chills-Severe, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Weakness-Severe
Headache, body aches, red, tender spot at injection site, used Tylenol, ibuprofen and Benadryl
Migraine for 4 weeks after; shocking feeling in body from legs to arms; stiff neck; dose 1 on 22May2021 10:30/ dose 2 on 22May2021; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at same age, dose 1 via an unspecified route of administration, administered in Arm Left on 22May2021 10:30 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration, administered in Arm on 22May2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included High blood pressure, and type 2 diabetes and both were controlled well, and allergies: Penicillin. Patient is not pregnant at time of vaccination. Patient did receive other medications within 2 weeks of vaccination. Migraine for 4 weeks after, shocking feeling in body from legs to arms, stiff neck and was caused emergency room/department or urgent care and hospitalized and seeing neurology doctor as symptoms are still here on 13Jun2021 07:00. The patient was hospitalized for 2 days. The treatment CT scan, MRI and visual watch were received for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of event Inappropriate schedule of vaccine administered was unknown while other events were recovering. Information regarding the lot/batch number has been requested.
THE PATIENT CALLED AND CLAIMED HIS SHOULDER IS STILL STIFF , SWOLLEN AND DIFFICULT TO MOVE. hE WILL GO TO DOCTOR ON aUGUST 23 ,2019 TO GET CHECKED.
Severe abdominal pain for 24 hours, fever, feeling of dehydration, fatigue.  Pain started to subside after 3 days, but is still acutely there.  Fever present for 48 hours.
COVID-19 positive 11/15/2022.I had a sore throat, drippy nose, fatigue, coughing and brain fog. I reached out to my PCP and was prescribed a course of Paxlovid. After completing Paxlovid I had a rebound of all my COVID-19 symptoms. I reached out again to my PCP to get medication but he did not prescribe another dose of the medication. Om 12/07 I had a follow up with my Pulmonologist she ordered an Xray to rule out Pneumonia and it was clear. I was prescribed a 3?4-day supply of prednisone to take as needed.